Mobile Airway System Improves Patient Lifestyles
|
By HospiMedica International staff writers Posted on 15 May 2017 |

Image: The Monarch Airway Clearance System (Photo courtesy of Hill-Rom Holdings).
A novel mobile respiratory care solution provides high frequency chest wall oscillation (HFCWO) to people suffering from long-term pulmonary issues.
The Hill-Rom Holdings Monarch Airway Clearance System is intended for patients suffering from a variety of issues that cause chest congestion and which cannot be cleared by conventional therapies such as drugs, chest physical therapy, special coughing techniques, or cough-assist aids. The wearable vest device has a sporty design, stylish shells, and a customizable, personalized fit. HFCWO is delivered via pulmonary oscillating discs (PODs) that provide targeted kinetic energy to the lungs in order to thin mucus and move it up and out of the lungs.
Designed to treat issues such as bronchiectasis, chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), muscular dystrophy, cerebral palsy, and chest congestion associated with more than 400 different medical conditions--including neuromuscular and immune disorders--the Monarch system also incorporates LTE and WiFi technology to keep patients wirelessly connected to their care team via the Hill-Rom VisiView Health Portal, a secure, cloud-based system that automatically receives information from respiratory care devices in a patient's home.
The secure therapy adherence data is then displayed on a user-friendly dashboard that facilitates data and trending information, which can then be used to enhance communication between health care teams and patients. The VisiView Health Portal thus supports informed care decisions and reduced risk of respiratory infections, hospitalizations, and medical costs. The Monarch Airway Clearance System has been approved by the U.S. Food and Drug Administration (FDA).
“I wanted to create a portable, long-lasting battery-powered device that clears the lungs so patients are free to be outside, go camping, live a fuller, higher quality of life,” said inventor Marten DeVlieger, a CF patient who collaborated with Hill-Rom to design the Monarch system. “It is exciting to see my vision for mobile therapy come true.”
HFCWO assist devices generate either positive or negative trans-respiratory pressure excursions to produce high-frequency, small-volume oscillations in the airways. The oscillations can lead to changes in mucus volume of 15–57 ml and in flow up to 1.6 L/s, which can generate minimal coughing to mobilize lung secretions. Typical treatments last 20–30 minutes, and consist of periods of compression at different frequencies, separated by coughing.
The Hill-Rom Holdings Monarch Airway Clearance System is intended for patients suffering from a variety of issues that cause chest congestion and which cannot be cleared by conventional therapies such as drugs, chest physical therapy, special coughing techniques, or cough-assist aids. The wearable vest device has a sporty design, stylish shells, and a customizable, personalized fit. HFCWO is delivered via pulmonary oscillating discs (PODs) that provide targeted kinetic energy to the lungs in order to thin mucus and move it up and out of the lungs.
Designed to treat issues such as bronchiectasis, chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), muscular dystrophy, cerebral palsy, and chest congestion associated with more than 400 different medical conditions--including neuromuscular and immune disorders--the Monarch system also incorporates LTE and WiFi technology to keep patients wirelessly connected to their care team via the Hill-Rom VisiView Health Portal, a secure, cloud-based system that automatically receives information from respiratory care devices in a patient's home.
The secure therapy adherence data is then displayed on a user-friendly dashboard that facilitates data and trending information, which can then be used to enhance communication between health care teams and patients. The VisiView Health Portal thus supports informed care decisions and reduced risk of respiratory infections, hospitalizations, and medical costs. The Monarch Airway Clearance System has been approved by the U.S. Food and Drug Administration (FDA).
“I wanted to create a portable, long-lasting battery-powered device that clears the lungs so patients are free to be outside, go camping, live a fuller, higher quality of life,” said inventor Marten DeVlieger, a CF patient who collaborated with Hill-Rom to design the Monarch system. “It is exciting to see my vision for mobile therapy come true.”
HFCWO assist devices generate either positive or negative trans-respiratory pressure excursions to produce high-frequency, small-volume oscillations in the airways. The oscillations can lead to changes in mucus volume of 15–57 ml and in flow up to 1.6 L/s, which can generate minimal coughing to mobilize lung secretions. Typical treatments last 20–30 minutes, and consist of periods of compression at different frequencies, separated by coughing.
Latest Critical Care News
- Automated IV Labeling Solution Improves Infusion Safety and Efficiency
- First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
- 4D Digital Twin Heart Model Improves CRT Outcomes
- AI Turns Glucose Data Into Actionable Insights for Diabetes Care
- Microscale Wireless Implant Tracks Brain Activity Over Time
- Smart Mask Delivers Continuous, Battery-Free Breath Monitoring
- Routine Blood Pressure Readings May Identify Risk of Future Cognitive Decline
- CGM-Based Algorithm Enhances Insulin Dose Adjustment in Type 2 Diabetes
- Fish Scale–Based Implants Offer New Approach to Corneal Repair
- Dual-Function Wound Patch Combines Infection Sensing and Treatment
- Smartwatch Signals and Blood Tests Team Up for Early Warning on Insulin Resistance
- Smart Fabric Technology Aims to Prevent Pressure Injuries in Hospital Care
- Standardized Treatment Algorithm Improves Blood Pressure Control
- Combined Infection Control Strategy Limits Drug-Resistant Outbreak in NICU
- AI Helps Predict Which Heart-Failure Patients Will Worsen Within a Year
- Algorithm Allows Paramedics to Predict Brain Damage Risk After Cardiac Arrest
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read moreSurgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







